Researchers
Belić, Jelena
Type
Date issued
Results 1-8 of 8
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2021 | A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study | Unseld M.; Belic J.   ; Pierer K.; Zhou Q.; Moser T.; Bauer R.; Piringer G.; Gerger A.; Siebenhüner A.; Speicher M.;
Heitzer E.;
| Article | 21aM21a |
| 2020 | Detection of ctDNA from dried blood spots after DNA size selection | Heider K.; Wan J.C.M.; Hall J.; Belić Jelena ; Boyle S.; Hudecova I.; Gale D.; Cooper W.N.; Corrie P.G.; Brenton J.D.;
Smith C.G.; Rosenfeld N.;
| Article | 21a+M21a+ |
| 2020 | Shallow whole-genome sequencing from plasma identifies FGFR1 amplified breast cancers and predicts overall survival | Bourrier C.; Pierga J.-Y.; Xuereb L.; Salaun H.; Proudhon C.; Speicher M.R.; Belić Jelena ; Heitzer E.; Lockhart B.P.; Guigal-Stephan N. | Article | 21aM21a |
| 2019 | Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection | Ulz P.; Perakis S.; Zhou Q.; Moser T.; Belic J. ; Lazzeri I.; Wölfler A.; Zebisch A.; Gerger A.; Pristauz G.;
Petru E.; White B.; Roberts C.E.S.; John J.S.; Schimek M.G.; Geigl J.B.; Bauernhofer T.; Sill H.; Bock C.; Heitzer E.; Speicher M.R.;
| Article | 21a+M21a+ |
| 2018 | Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide | Belic J. ; Graf R.; Bauernhofer T.; Cherkas Y.; Ulz P.; Waldispuehl-Geigl J.; Perakis S.; Gormley M.; Patel J.; Li W.;
Geigl J.B.; Smirnov D.; Heitzer E.; Gross M.; Speicher M.R.;
| Article | 21aM21a |
| 2018 | Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide | Belic J. ; Graf R.; Bauernhofer T.; Cherkas Y.; Ulz P.; Waldipuehl-Geigl J.; Perakis S.; Gormley M.; Jaymala P.; Weimin L.;
Geigl J.B.; Smirnov D.; Heitzer E.; Mitchell G.; Speicher M.A.;
| Conference Paper | Mp. category will be shown later |
| 2017 | Characterisation and treatment of patients with castration-resistant metastatic prostate cancer (mCRPC) developing neuroendocrine clonal divergence (NCD): A case series | Bauernhofer T.; Belic J. ; Pichler M.; Bezan A.; Heitzer E.; Geigl J.B.; Stoger H.; Speicher M.; Smolle M.A. | Conference Paper | Mp. category will be shown later |
| 2017 | Praktikum iz medicinske biohemije | Belić, Jelena ; Jovanović-Galović, Aleksandra | Text book | Mp. category will be shown later |